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ABSTRACT
Introduction: Governments in different countries have
committed to better use of evidence from research in
policy. Although many programmes are directed at
assisting agencies to better use research, there have
been few tests of the effectiveness of such
programmes. This paper describes the protocol for
SPIRIT (Supporting Policy In health with Research: an
Intervention Trial), a trial designed to test the
effectiveness of a multifaceted programme to build
organisational capacity for the use of research evidence
in policy and programme development. The primary
aim is to determine whether SPIRIT results in an
increase in the extent to which research and research
expertise is sought, appraised, generated and used in
the development of specific policy products produced
by health policy agencies.
Methods and analysis: A stepped wedge cluster
randomised trial involving six health policy agencies
located in Sydney, Australia. Policy agencies are the
unit of randomisation and intervention. Agencies were
randomly allocated to one of three start dates (steps)
to receive the 1-year intervention programme,
underpinned by an action framework. The SPIRIT
intervention is tailored to suit the interests and needs
of each agency and includes audit, feedback and goal
setting; a leadership programme; staff training; the
opportunity to test systems to assist in the use of
research in policies; and exchange with researchers.
Outcome measures will be collected at each agency
every 6 months for 30 months (starting at the
beginning of step 1).
Ethics and dissemination: Ethics approval was
granted by the University of Western Sydney Human
Research and Ethics Committee HREC Approval H8855.
The findings of this study will be disseminated broadly
through peer-reviewed publications and presentations
at conferences and used to inform future strategies.
INTRODUCTION
Internationally, there is a growing commit-
ment to better use of evidence from research
in policy, with a view to improving outcomes
and optimising resource allocation.1–4 As a
result, considerable attention has recently
been given to assisting government agencies
to better use evidence from research in
policy and programme design.
Health policies and programmes have been
a particular focus, and a number of
approaches to building skills and organisa-
tional capacity to use evidence from research
have been developed.5 6 The target for these
programmes is government agencies who
develop national or regional policy and pro-
grammes rather than organisations that
provide health services and clinical care.
Despite the proliferation of such programmes
and their cost to government, there have
been few examinations of their impact on the
use of research. A recent comprehensive
review7 found only ﬁve studies examining the
impact of strategies to increase the use of evi-
dence in policy and since that time, to the
best of our knowledge, only one other rele-
vant study protocol has been published.8
The paucity of trials may be partly a result
of the considerable challenges in evaluating
the impact of strategies designed to increase
the use of research in policy and programme
design. Agencies involved in policy and pro-
gramme development, even within health,
are heterogeneous—they will be different in
remit, size, proximity to central government
and in their need for and current capacity to
use evidence from research. These agencies
are also often complex organisational systems
and may respond very differently to the same
strategy programme. Effective strategies will
therefore most likely be multicomponent
and highly tailored to meet the needs of dif-
ferent agencies. Study designs will need to be
capable of assessing complex interventions
and of carefully measuring the context in
which the programme is delivered; it is most
likely that the programme will need to be
delivered at the level of the health policy
agency, which means a cluster design will be
required. It may not be feasible to recruit
and intervene with sufﬁcient agencies to
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power a randomised controlled trial. A further challenge
lies in the lack of established validated measures of the
use of research in policy and programme development;
in a trial context, an objective measure of the impact of
the programme is required.
This paper describes SPIRIT (Supporting Policy In
health with Research: an Intervention Trial), an evaluation
of the impact of a multifaceted programme designed to
build the capacity of health policy agenciesi to use research
in policy and programme development. The trial is based
on the SPIRIT Action Framework described in detail else-
where; the Framework hypothesises that the use of research
in policy is mediated by the capacity of the organisation to
use research (including the extent to which the agency
values research, has systems in place to use research and
the skills of its staff). It predicts that greater capacity will
lead to more research engagement actions (demonstrated by
accessing and appraising existing research, generating new
research and interacting with researchers) and that, in
turn, more engagement actions will result in a greater use of
research evidence.
SPIRIT is a stepped wedge trial evaluating a complex
intervention and using an objective measure for its
primary outcome. It extends previous studies which
often evaluated only one strategy,10–12 did not use object-
ive outcome measures10 11 13 and were unable to
include a detailed process evaluation.10–14 In addition,
SPIRIT is the only trial designed to bring about organ-
isational change in policy and programme agencies and
that has the capacity to assess the long-term impact of
the programme (up to 18 months after its completion).
AIMS
Objective and aims
The objective of the trial is to examine what impact the
SPIRIT intervention has and how it works in the ﬁeld.
Our primary outcome measure is an objective assess-
ment made by an expert panel, our secondary measures
utilise self-informant or key informant reports and our
process evaluation includes coded and descriptive
accounts of the intervention delivery and participation
made during observations of sessions, semistructured
interviews and written participant feedback. We will
examine these data across the components of the
SPIRIT Action Framework (capacity, research engage-
ment actions and use of research evidence); this will
enable us to examine the impact of the SPIRIT interven-
tion programme and to test the causal relationships
hypothesised by the model. By capacity, we mean the
extent to which the agency values research, has systems
in place to use research and the skills of its staff. By
research engagement actions, we mean the extent to which
research is accessed, appraised and generated, and
where interaction with researchers occurs, in relation to
the development of a speciﬁc policy or programme
document. By research use, we mean the extent to which
research is sought and used in developing the policy or
programme document, taking into account barriers and
facilitators.
The speciﬁc aims are:
Primary outcome
1. To determine, using an objective measure, whether
the SPIRIT intervention results in an increase in the
extent to which research engagement actions are
undertaken, and research is used in the development
of policy and programme documents.
Secondary outcome
1. To determine, using the self-report of staff members,
whether the SPIRIT intervention results in an
increase in:
▸ The capacity of health policy agencies to use
research in terms of: (A) the value placed on the
use of research evidence by individual policy-
makers and by the organisation; (B) the conﬁ-
dence of policymakers in undertaking research
actions and using research and (C) the systems
and tools the organisation has in place to support
research use;
▸ Research engagement actions;
▸ The use of research.
Process evaluation: The aim of the process evaluation is
to complement the outcome measures by exploring how
and why the intervention worked or did not work in dif-
ferent contexts. This includes descriptions of:
1. The implementation of the intervention programme,
including the delivery of the essential elements (ﬁdelity);
2. Participation in and responses to the intervention
(eg, how people interacted with the programme, how
they evaluated different aspects of it and what sort of
change they experienced, if any);
3. Contextual factors that might have affected the pro-
gramme and responses to it (eg, agency priorities,
practice norms, other training or organisational
change initiatives, relationships with external bodies,
legislative reform).
Cost analysis
1. To document the cost of delivering the intervention.
Methods
SPIRIT started in October 2012, and at the time of
writing, approximately one-half of the total intervention
period of 30 months has been completed.
Trial design
SPIRIT is a stepped wedge cluster intervention trial
(ﬁgure 2) involving six agencies. Two agencies are ran-
domly assigned to each step. This design is a variation on a
cross-over design where each intervention unit is measured
in the control and intervention phases, except that the step
iFor the purposes of SPIRIT, a health policy agency is deﬁned as: A
body within a state or federal government department, or a statutory
authority, whose focus is to develop policy which has an impact on
state-wide or national services and programmes intended to improve
individual, family or community health.9
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wedge design involves a cross-over in one direction only.
The key feature of this design is that the intervention is
rolled out sequentially over a number of time periods,
such that all trial units have received the intervention by
the end of the trial, although the order in which they
receive it is determined at random.15 16 Outcome mea-
sures are obtained at the same time in all sites, at base-
line and after implementation in each site. This design
was selected in accordance with the UK Medical
Research Council17 recommendations because the inter-
vention is delivered at the level of the health policy
agency (cluster) and recruiting and intervening with a
large enough number of policy agencies to power a trad-
itional randomised controlled trial was unfeasible due
to the resource-intensive nature of SPIRIT and its status
as a new, untested programme.
Figure 1 The programme logic
for Supporting Policy In health
with Research: an Intervention
Trial (SPIRIT).
Figure 2 SPIRIT design. LP, liaison person; SPIRIT, Supporting Policy In health with Research: an Intervention Trial.
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Participants
Recruitment of health policy agencies
The inclusion and exclusion criteria for policy agencies
were established prior to recruiting trial participants. An
agency was eligible to participate in SPIRIT if: (A) a sig-
niﬁcant proportion of its work was in health policy or
programme development; (B) at least 20 staff members
were involved in policy or programme design, develop-
ment or evaluation; and (C) it was located in Sydney
(for ease of provision of the programme).
Government websites which list all New South Wales
and Australian government health policy and pro-
gramme agencies were used to identify potentially eli-
gible agencies located in Sydney, New South Wales
(where most of the major health policy agencies in the
state are located). Information from the website of each
agency was reviewed by members of the investigator
team with policy experience to exclude those agencies
without a signiﬁcant focus on health and on policy or
programme design, development or evaluation.
Seventy-ﬁve agencies were classiﬁed as potentially eli-
gible and email and/or phone contact was made with
each agency to determine the number of relevant staff
members. Following this step, the 16 agencies still
regarded as potentially eligible were ranked to deter-
mine those with the greatest speciﬁc focus on health
and the largest numbers of relevant staff. A visit was
made by two of the authors (SR and NL) to the top six
ranked agencies, all of whom agreed to take part. The
agencies which agreed to participate in SPIRIT comprise
a major centre within the New South Wales Ministry of
Health and ﬁve agencies (four state and one national)
that develop policy and programmes about speciﬁc
aspects of health.
Intervention
Development of the intervention programme
The intervention programme is underpinned by the
programme logic shown in ﬁgure 1.
The intervention was designed to be appropriate for
policy agencies, taking into account that they are sophis-
ticated, complex organisations with skilled staff and
diverse policy priorities. The design of the programme
was strongly inﬂuenced by cognitive behavioural
theory,18 19 system science,20 21 organisational change
theory22–25 and adult learning theories.26 27 We used
these approaches, together with information from inter-
views with policymakers and experience from existing
programmes in Australia28–30 and internationally,5 6 10 14
to identify factors that have been associated with signiﬁ-
cant individual or organisational change. Telephone
interviews were then conducted with nine senior
Australian health policymakers to canvass their views
about the kinds of strategies being considered for inclu-
sion in the intervention. They endorsed our approach,
indicating that the proposed change strategies were
acceptable and would most likely make a difference in
improving the use of research evidence in policymaking.
Components of the intervention and all three mea-
sures were piloted in a policy agency that was not part of
SPIRIT prior to the start of the study. This pilot broadly
conﬁrmed that the proposed methods were acceptable
and appropriate and allowed ﬁne tuning of some
aspects of the intervention.
SPIRIT: THE PROGRAMME
The SPIRIT intervention is a six-component programme
(table 1):
1. Audit, feedback and goal setting: SPIRIT begins with the
provision of a facilitated discussion of the ﬁndings
from the agency’s preintervention measures (see
below) to the individuals that each agency nominates
to be part of their ‘leaders’ group. One of the authors
(SR) facilitates these sessions and encourages the
leaders to reﬂect on and discuss the current strengths
of the agency in using evidence from research, and
opportunities for improvement based on the preinter-
vention data. The discussion is used to (A) agree on
priorities for change; (B) select the elective elements
of the SPIRIT programme (see table 1) and (C) iden-
tify other actions outside the scope of the SPIRIT pro-
gramme that the agency might wish to undertake to
increase its use of evidence in policy.
2. Leadership programme: This component provides an
opportunity for agency-nominated leaders to con-
sider the value of research in their work, current
approaches to knowledge exchange and how to bring
about a greater use of evidence from research in
their agency. It draws on the CFHCI EXTRA pro-
gramme,5 and consists of two interactive workshops
led by experts in knowledge exchange and policy
development.
3. Agency support for research: This component is designed
to strengthen the perception among staff that their
organisation values the use of evidence and to
provide tools for structural change. It includes (A) a
quarterly email sent to all staff in each agency by the
chief executive (CE). The email aims to demonstrate
CE support for the use of evidence in the agency’s
work and is drafted by the research team and contex-
tualised by the CE; (B) access to Web CIPHER
(Centre for Informing Policy in Health with Evidence
from Research), an online resource for policymakers
where users can access research, hear from opinion
leaders, share knowledge and debate ideas about the
use of research in policymaking and programme
development and (c) provision of relevant fact sheets
and key publications.
4. Systems for accessing research, commissioning a review and
analysing relevant data: This component gives agencies
an opportunity to trial existing systems for helping
agencies to use research evidence. The agency elects
to trial the system for one of: a brokered rapid review
of research evidence around a topic of interest; a bro-
kered analysis of local data or the development of an
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Table 1 Overview of the intervention components and subcomponents, their delivery mode and goals
Components
Intervention subcomponents/
sessions Format/mode Goals
Audit, feedback and
goal setting
1. Feedback forum* Interactive feedback (from the preintervention
measures) forum for executive staff. Opportunities
for improvement are identified.
Further feedback sessions are provided
mid-intervention and at the conclusion of the trial
Leaders make informed decisions about
opportunities for growing their agencies’ capacity
to use research
Leadership programme 1. Leading organisational change*
2. Supporting the use of evidence in
the team*
Interactive forums for executive staff. Forum 1
presents feedback about the agency’s use (see
above). Forums 2 and 3 explore how leaders can
build capacity. Forums provided by policy experts
and leaders in knowledge exchange. Real world
examples and collaborative problem-solving used
Leaders can identify modifiable barriers to
research-informed policy/programme development
and identify strategies for reducing them in their
agencies
Agency support for
research
1. Quarterly email endorsements
from the participating agency
CEO*
2. Web CIPHER
3. Tools and resources
1. CEO email to all staff supporting SPIRIT,
promoting the use of research in agency and
providing links to relevant resources
2. Access via Web CIPHER to new research,
evidence libraries and research expertise
3. Provision of useful information at R4P
sessions, such as key publications from
leaders in knowledge exchange
1. Staff see that their senior leader values the use
of research in policy/programme work and that
they (staff) have increased regard for the value
of research in policy/programme work
2. Staff are given access to research resources
3. Staff attending R4P events receive hardcopy
resources to guide action responses
Opportunity to test
systems for accessing
research and reviews
1. A brokered rapid review or the
development of an evaluation plan
or a brokered analysis of local
linked data†
Intervention officers and nominated staff negotiate
the product requirements (research questions,
timelines, deliverables, etc). Expert researchers
develop the product or consult on its development.
Agency staff may be as involved in the process of
developing the product as they wish
Staff gain experience commissioning a review/an
evaluation/a piece of linked data analysis
Agencies have a research product that directly
addresses a current priority or concern and use it
to inform their policy/programme work
Research exchange 1. Research exchanges Δ
2. E-bulletins Δ g 1. A tailored interactive form that brings togetherresearchers and policymakers around a topic
specified by the agency
2. Receipt of a summary of recently published
systematic reviews relevant to the agency’s
work
Staff receive accessible research information that
directly addresses current priorities or concerns
and use it to inform their policy/programme work
Continued
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evaluation framework related to an aspect of the
agency’s work. A tailored research product is pro-
duced for each agency as a result of this process.
5. Research access: In this component, agencies choose
three occasions of facilitated access to research or
researchers—this might be (A) a tailored interactive
forum that brings together researchers and policy-
makers around a topic speciﬁed by the agency; or
(B) receipt of a summary of recently published sys-
tematic reviews relevant to the agency’s work.
6. Staff training and skill development: This component is
designed to increase the value placed on the use of
research in policy (symposium 1, received by all agen-
cies) and to increase skills in areas selected by the
agency (symposia 2–3, topics selected by the agency).
The workshops are provided by individuals with
expertise appropriate to the topic, include tailored
case studies and draw on adult learning principles.
Symposium 1 includes feedback on the current use
of evidence from research by the agency and sympo-
sia 2 and 3 might address any of the following
depending on the interests of the agency: accessing
and applying systematic reviews; skills for appraising
research; policy and programme evaluation (intro-
duction to evaluation or evaluation in practice);
working with researchers or commissioning research
for policy and programme development.
The active phase of the intervention runs for
12 months with around one activity in each agency per
month. There are no costs to agencies for any compo-
nent, other than the opportunity cost associated with the
time taken for their staff to participate. The CE of each
participating agency was asked to nominate a senior
member of staff to function as the liaison person (LP)
and to be the primary point of contact for the SPIRIT
team. An individual with extensive knowledge of broker-
ing experience was appointed as the SPIRIT ofﬁcer for
each agency and worked with the LP to ensure that
SPIRITwas provided effectively at that agency.
Timing of recruitment, intervention delivery and follow-up
As shown in ﬁgure 2, the SPIRIT programme runs for
12 months in each health policy agency. The total meas-
urement period is 30 months with measures being col-
lected at the beginning of the study period, and then
every 6 months thereafter in each agency. There are
thus six measurement points in total. The ﬁrst measure-
ment point is a preintervention measure for all agencies
and the ﬁnal measurement point is 6 months after the
completion of the SPIRIT programme in the last rando-
mised pair of agencies.
Outcomes
Primary outcome
1. The primary outcome is an objective measure
(SAGE, described below) of whether the SPIRIT
intervention results in an increase in the extent to
which research engagement actions are undertaken
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and research is used in the development of policy
and programme documents.
Secondary outcomes
1. To determine, using the self-report of staff members
(SEER and ORACLe, described below), whether the
SPIRIT intervention results in an increase in:
▸ The capacity of health policy agencies to use
research in terms of: (A) the value placed on the
use of research evidence by individual policy-
makers and by the organisation; (B) the conﬁ-
dence of policymakers in undertaking the
research actions and using research; and (C) the
systems and tools the organisation has in place;
▸ Research engagement actions;
▸ The use of research.
Process evaluation: The third set of outcomes was col-
lected as part of a process evaluation and describes the
implementation of SPIRIT in health policy agencies
including data around:
A. SPIRIT components selected by each agency;
B. Participants’ engagement;
C. The ﬁdelity of delivery;
D. The cost of delivery.
Outcome measurement
All outcome measures used in SPIRIT have been devel-
oped speciﬁcally for the trial as we were unable to iden-
tify any suitable measures in the literature. All measures
were extensively piloted prior to the start of the trial and
papers outlining their development and validation will
be published in peer-reviewed journals. Table 2 provides
a summary of the primary and secondary study out-
comes and the accompanying outcome measurement
tools.
1. Staff Assessment of enGagement with Evidence (SAGE) is
an objective measure of the primary outcome—the
extent to which agencies apply research ﬁndings in
the development of the policy and programme docu-
ments they produce. An expert panel will be
assembled to assign SAGE scores on the basis of
interview data and document review. At each of the
six data points, agencies are asked to provide the
four policy documents ﬁnalised during the past
6 months that best represent the use of research in
their policy and programme development work. The
level of measurement is the policy document.
Information about each document is collected via a
structured qualitative interview with an individual
who was heavily involved in the development of the
document, nominated by the LP. The interview runs
for approximately 1 h. A separate interview is con-
ducted for each nominated document. The domains
SAGE assesses are: (A) research engagement actions
(accessing research, appraising research (for quality
and relevance), generating new research or analysis
and interacting with researchers)—each of these six
dimensions receives a score from 0 to 9. Scores can
be summed or reported separately; (B) outcome:
research use (four types of research use are considered:
instrumental, tactical, conceptual and imposed).
Each of these four dimensions receives a score from
0 to 9. Scores can be summed or reported separately.
2. Seeking, Engaging with and Evaluating Research (SEER)
measures individual policymakers’ capacities,
research engagement actions and research use. SEER
is administered via an online self-report survey to eli-
gible policymakers identiﬁed by the LP. At each of
the six measurement points, the LP from each
agency provides a list of eligible policymakers to the
research team.
Health policy or programme staff are regarded as eli-
gible to complete SPIRIT measures if:
A. They write health policy documents or develop
health programmes, or make or contribute signiﬁ-
cantly to policy decisions about health services, pro-
grammes or resourcing;
B. They are employed at a mid-level or higher in their
agency;
C. They are over 18 years of age and consent to partici-
pate in the study.
Individual agency staff members are excluded if they
are contractors and/or work across several of the partici-
pating agencies. All nominated policymakers are
emailed an invitation to participate in the SPIRIT trial
outcome measure in question along with standard par-
ticipant information and consent forms. SEER measures
(A) capacity (four subscales: predisposing factors related
to individual values, perceptions of organisational
values, perception of organisational systems and individ-
ual knowledge); (B) research use actions (accessing
research, appraising, generating new research or ana-
lyses and interacting with researchers); and (C) research
use (conceptual, instrumental, tactical and imposed
research use) and extent of research use.
1. Organisational Research Access, Culture and Leadership
(ORACLe) is used to assess each agency’s capacity to
use research ﬁndings. ORACLe data are collected via
a structured qualitative interview with a senior staff
member from each agency, nominated by the agency
LP. The qualitative data are transcribed and used to
assign scores to seven dimensions related to an orga-
nisation’s capacity to use research. Two researchers
separately score the responses (0=no, 1=yes—some or
to a limited extent, 2=yes—very much so) of each
participant to the 21 questions which make up the
ORACLe scale. Inter-rater reliability has thus far been
high (95%). Scores for each domain and a total
score are then generated using an algorithm devel-
oped via a discrete choice experiment. This experi-
ment harnessed the views of leaders in policy and
knowledge exchange on the most important agency-
level factors inﬂuencing the use of evidence.
ORACLe assesses agencies across the following seven
domains: (A) processes that encourage or require the
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Table 2 SPIRIT outcome measures
Outcome
Level of
assessment Tool
Data collection
method Participants Domains
Primary outcome measure
Use of research in the
creation of policy
documents
Policy
document
SAGE Interview
(face-to-face or
phone) plus
collection of
documentation
One or two policymakers
involved in the
development of the policy
document being
considered×four
documents at each
measurement point
▸ Seeking research
– Research access efforts
– Appraisal of relevance
– Appraisal of quality
▸ Using research
– Conceptual research use
– Instrumental research use
– Tactical research use
– Imposed research use
– Influence of research
▸ Generating research
– Plans to generate or advocate new research
▸ Influences on research use in policy
– Barriers to research use
– Enablers of research use
Secondary outcome measures
Policymakers’
self-assessments
of their research use
capacity, actions and
outcomes
Individual
policymaker
SEER Online survey All policymakers from
within participating
agencies
▸ Access to, and appraisal, generation and use of research
▸ Engagement with researchers
▸ Value placed on research
▸ Confidence in using research
▸ Perceived value organisation places on use of research
▸ Organisational tools and systems available to support research use
Organisational capacity
to use research as
measured by the
existing tools and
systems to support
research use
Policy
agency
ORACLe Interview
(face-to-face or
phone) plus
collection of
documentation
One senior member of
each policy agency,
nominated by agency’s
leaders
▸ Policies that encourage or mandate the examination of research in
policy and programme development
▸ Tools and programmes to assist leaders of the organisation to
actively support the use of research in policy and programme
development
▸ Strategies to provide staff with training in using evidence from
research in policy and in maintaining these skills
▸ Strategies to help staff to access existing research findings
▸ Methods to generate new research evidence to inform the
organisation’s work
▸ Methods to ensure adequate evaluations of the organisation’s
policies and programmes
▸ Strategies to strengthen research relationships
ORACLe, Organisational Research Access, Culture and Leadership; SAGE, Staff Assessment of enGagement with Evidence; SEER Seeking, Engaging with and Evaluating Research; SPIRIT,
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examination of research in policy and programme devel-
opment; (B) tools and programmes to assist leaders of
the organisation to actively support the use of research
in policy and programme development; (C) strategies to
provide staff with training in using evidence from
research in policy and in maintaining these skills; (D)
organisational strategies to help staff to access existing
research ﬁndings; (E) methods to generate new research
evidence to inform the organisation’s work; (F) methods
to ensure adequate evaluations of the organisation’s pol-
icies and programmes; and (G) strategies to strengthen
research relationships.
Process evaluation
A mixed methods process evaluation is conducted in
parallel with the intervention in each of the six agencies.
It collects data about, and analyses the interactions
between, three domains:
A. The delivery of the intervention, including implementa-
tion of essential elements (ﬁdelity). All intervention ses-
sions are observed and audio recorded by process
evaluation staff. Initial essential elements (ie, aspects
of each intervention component that are considered
critical to its success) are identiﬁed, and codes devel-
oped to monitor their delivery descriptively and,
where possible, quantitatively. Essential elements and
codes are tested in the early stages of the programme
delivery, reﬁned and further tested throughout the
trial. Revised elements are applied retrospectively to
earlier sessions to enable comparison across interven-
tion sites.
B. Participation in and responses to the intervention:
Participation attributes are recorded during session
observations, and self-report evaluation forms are
used to collect feedback on the relevance, applicabil-
ity and value of each intervention session from the
participants’ point of view, including whether they
are likely to use knowledge/skills developed in the
session. Following the intervention, ﬁve to seven
semi-structured interviews are conducted in each site
which explore participants’ responses to the pro-
gramme, including changes in relation to individual
and organisational capacity to use research, research
engagement actions and actual research use.
C. Contextual factors that might have affected the intervention
and responses to it: Session observations are used to
collect data on participants’ views and experiences of
research use in their work. Preintervention interviews
with participants explore workplace priorities and
culture, how they perceive their organisations’
support for research use, the role of research within
the mix of other information and any other context-
ual factors that affect their use of research or may
affect how they will engage with and respond to the
intervention, including exposure to other research
use drivers.
The process evaluation will complement the outcome
measures by describing how and why the intervention
worked or did not work, including why the same inter-
vention strategies may have had different effects in dif-
ferent contexts.31–33 In addition, it will aid future
programme improvement by identifying beneﬁcial
design and implementation strategies and suggesting
contextually responsive programme adaptation for dif-
ferent recipients and settings. The full protocol for the
SPIRIT process evaluation is described in detail
elsewhere.
Cost analysis
A cost analysis is being conducted as part of SPIRIT
because: the intervention will include non-market goods
for which standardised cost estimates are less likely to
exist. This cost analysis is conducted from the perspec-
tive of the intervention provider; detailed data on the
resources used to deliver the intervention and their
values are collected via interviews with central interven-
tion staff, logging of the costs involved in hiring session
facilitators, interviews with agency liaison people regard-
ing the time taken to complete their SPIRIT tasks,
recording the length of interviews, monitoring the time
taken to complete the SEER online surveys and careful
record keeping regarding the duration of sessions.
Microcosting (a bottom-up approach methodology) is
being used.34
Randomisation
The health policy agency is the unit of randomisation
and intervention in the SPIRIT trial, with two sites ran-
domised to start the intervention at each ‘step’. The six
participating agencies were each assigned a code. The
list of agency codes was sent to a biostatistician who was
not involved in any other aspect of the trial, who
assigned each agency code a computer-generated
random number sequence and resorted them. The ﬁrst
two agencies in the list were allocated the October 2012
start date (step 1), the second two the April 2013 start
date (step 2) and the ﬁnal two the October 2013 start
date (step 3).
Blinding
The SPIRIT staff and those investigators involved in deli-
vering aspects of the intervention, by necessity, are not
blind to allocation. All other investigators are blind to
allocation, although analysis will need to know when
sites start the intervention. They will not be informed
which agencies are in the active intervention phase, and
all questionnaire responses and interview records that
they receive will be de-identiﬁed for individual partici-
pants. The agency allocation is concealed from those
scoring SAGE and ORACLe to limit bias; this is particu-
larly important since the intervention team cannot be
blinded to the active intervention agencies.
Statistical methods
Analysis will be undertaken using generalised linear
models with a link function and error distribution
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appropriate to the outcome measure. In each model,
the intervention effect will be estimated as the differ-
ence between the postintervention and preintervention
levels of the outcome after adjusting for time. The unit
of analysis will be the agency for the SAGE and ORACLe
outcome measures and the individual for the SEER
outcome measure. Since there are too few clusters to
employ either a linear mixed model or a generalised
estimating equation (GEE) approach, all models will
adjust for the clustering by using agency as a ﬁxed
effect.
For the study design outlined in ﬁgure 2 and with the
assumption of an intraclass correlation coefﬁcient of
0.01, a total sample size of 144 documents, 4 per site per
time period, will give 89% power to detect a 1 SD differ-
ence in the mean SAGE total score at the 5% signiﬁ-
cance level.16
Data management and monitoring
Data for the SEER measure are entered online by parti-
cipants. SEER is primarily multiple choice. In order to
enhance data quality, the online survey has built in skip
functions and participants are unable to progress from
one page to the next until all questions are answered.
Data from SAGE and ORACLe are transcribed (the
scoring and checking procedure was described in the
outcome measures section).
All data and documents are stored on password pro-
tected computers and on a network server accessible
only to the researchers. Any paper documents are stored
in a securely locked ﬁling cabinet located at the Sax
Institute, which has day-to-day management of CIPHER.
The Sax Institute is a secure facility requiring a unique
staff access code to enter; visitors are escorted on-site
and are required to sign in.
A data monitoring committee was not required for
this trial as the risk of harm to participants is negligible.
Ethics and dissemination
All participants provide electronic consent to participate
in outcome measures via return email, and signed
consent for process evaluation data collection. All par-
ticipating agencies and individuals are free to decline to
participate in any and all aspects of SPIRIT at any time
with no explanation required (example participant
information and consent forms in online supplementary
appendix 1).
Participating agencies receive feedback on their results
at regular intervals during the active phase of the inter-
vention and again at the conclusion of the trial. The
ﬁndings of this study will be disseminated more broadly
through peer-reviewed publications (authorship deter-
mined by BMJ guidelines) and presentations at confer-
ences and used to inform future strategies.
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